Recurrent Cellulitis Associated with Long-Term Intrathecal Opioid Infusion Therapy: A Case Report and Review of the Literature

Pain Medicine

Volumn 11, Issue 6, 2010, Pages 972-976

  Ruan, Xiulu ^a   Liu, HaiNan ^b   Couch, J Patrick ^a   Wang, Frank ^c   Chiravuri, Srinivas ^d  

^a Physician's Pain Specialists of Alabama   (United States)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cellulitis; Edema; Intraspinal Drug Delivery; Intrathecal Hydromorphone; Intrathecal Morphine

Indexed keywords

BACLOFEN; CEFALEXIN; CEFAZOLIN; CLONIDINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROMORPHONE; MORPHINE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIA; ARTICLE; CASE REPORT; CELLULITIS; CHRONIC PAIN; COMPRESSION GARMENT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HOSPITALIZATION; HUMAN; INTRACTABLE PAIN; LEG EDEMA; LEG PAIN; LOW BACK PAIN; MEDICAL LITERATURE; PATIENT SATISFACTION; RECURRENT DISEASE; VISUAL ANALOG SCALE; CHEMICALLY INDUCED; EDEMA; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT OUTCOME;

ANALGESICS, OPIOID; BACLOFEN; CELLULITIS; CLONIDINE; EDEMA; FEMALE; GABA AGONISTS; HUMANS; HYDROMORPHONE; INJECTIONS, SPINAL; LOW BACK PAIN; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 77954448645     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00854.x     Document Type: Article

References (44)

1. Krames E. Intraspinal analgesia for nonmalignant pain. Interventional Pain Management 2001, 60:609-19. Waldman S. 2nd, edition, London, WB Sauders
2. Raphael JH, Southall JL, Gnanadurai TV, Treharne GI, Kitas GD. Long-term experience with implanted intrathecal drug administration systems for failed back syndrome and mechanical low back pain. BMC Musculoskeletal Disord 2002, 3:17.
3. Deer T, Chapple I, Classen A. Intrathecal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain. Pain Med 2004, 5:6-13.
4. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: Long-term benefits and efficacy. Surg Neurol 2001, 55:79-88.
5. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmaligmant pain. Neurosurgery 1999, 44(2):289-300.
6. Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician 2007, 10:357-65.
7. Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth 1995, 42(10):891-903.
8. Aldrete JA, Couto Da Silva JM. Leg edema from intrathecal opiate infusions. Eur J Pain 2000, 4:361-5.
9. Anderson VC, Cooke B, Burchiel KJ. Intrathecal hydromorphone for chronic nonmalignant pain: A restrospective study. Pain Med 2001, 2(4):287-97.
10. Bonnetblanc J-M, Bédane C. Erysipelas recognition and management. Therapy in practice. Am J Clin Dermatol 2003, 4(3):157-63.
11. Stalbow J. Preventing cellulitis in older people with persistent lower limb edema. Br J Nurs 2004, 13(12):725-32.
12. Swartz MN. Clinical practice. Cellulitis. N Eng J Med 2004, 350(9):904-12.
13. Sachs MK. The optimum use of needle aspiration in the bacteriological diagnosis of cellulitis in adults. Arch Intern Med 1990, 150:1907-12.
14. Sigurdsson AF, Gudmundsson S. The etiology of bacterial cellulitis as determined by fine-needle aspiration. Scand J Infect Dis 1989, 21:537-42.
15. Dupuy A, Benchikhi H, Roujeau JC. Risk factors for erysipelas of the leg(cellulitis): Case-control study. BMJ 1999, 318:159-4.
16. Baddour LM. Cellulitis syndrome: An update. Int J Antimicrob Agents 2000, 14:113-16.
17. Ruan X, Tadia R, Couch JP, Ruan J, Chiravuri S. Case report: Severe peripheral edema during an outpatient continuous epidural morphine infusion trial in a patient with failed back surgery syndrome. Pain Physican 2008, 11(3):363-8.
18. Huidobro-Toro J, Huidobro F. Central effects of morphine, levorphanol,(-)-methadone and the opioid-like peptides beta-endorphin and d-alanien2-methionine enkephalinamide on urine volume outflow and electrolytes. J Pharmacol Exp Ther 1981, 217:570-85.
19. Danesh S, Walker LA. Effects of central administration of morphine on renal function in conscious rats. J Pharmacol Exp Ther 1988, 244(2):640-5.
20. Mercadante S. Opioid rotation for cancer pain: Rationale and clinical aspects. Cancer 1999, 86:1856-66.
21. Lawlor PG, Turner KS, Hanson J, Bruera ED. Dose ratio between morphine and methadone in patients with cancer pain: A retrospective study. Cancer 1998, 82:1167-73.
22. Houde RW. Clinical analgesic studies of hydromorphone. Adv Pain Res Ther 1986, 8:129-35.
23. Deer T, Krames ES, Hassenbusch SJ. Polyanalgesic consensus conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation 2007, 10:300-28.
24. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of non-malignant etiology. J Neurosurg 1996, 85:458-67.
25. Di Chiro G. Observations on the circulation of the CSF. Acta Radiol 1996, 5:988-1002.
26. Fisher R. A consensus statement regarding the present suggested titration for Prialt(Ziconotide). Neuromodulation 2005, 8:153-4.
27. Cohen SP, Dragovich A. Intrathecal analgesia. Med Clin N Am 2007, 91:251-70.
28. Staats P, Whitworth M, Barakat M, Anderson W, Lilienfeld S. The use of implanted programmable infusion pumps in the management of nonmalignant chronic low-back pain. Neuromodulation 2007, 10:376-80.
29. Kehnscherper H, Rudolph S, Freitag B. Implantable drug pumps for spinal opioid analgesia: Technical solutions and problems. Anaesthesiol Reanim 2004, 29:74-8.
30. Bridenbaugh PO, Greene N, Brull S. Spinal (subarachnoid) neural blockade. Neural Blockade in Clinical Anesthesia and Management of Pain. Philadelphia 1988, 203-41. Cousin MJ, Bridenbaugh PO, eds., New York, Lippincott-Raven
31. Yaksh TL, Reddy SV. Studies in the primate on the anlagetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology 1981, 54:451-67.
32. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985, 22:845-58.
33. Kamisaki Y, Hamada T, Maeda K, Ishimura M, Itoh T. Presynaptic alpha2 adrenoceptors inhibit glutamate release from rat spinal cord synaptosomes. J Neurochem 1993, 60:522-6.
34. Rauck RL, Eisenach JC, Jackson K, Young LD, Southern J. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993, 79:1163-9.
35. Ackerman LL, Follett KA, Rosenquist RW. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combination. J Pain Symptom Manag 2003, 26:668-77.
36. Glynn CJ, Jamous MA, Teddy PJ, Moore RA, Lloyd JW. Role of spinal noradrenergic system in transmission of pain in patients with spinal cord injury. Lancet 1986, 2:1249-50.
37. Hassenbusch SJ, Gunes S, Wachsman S, Willis KD. Intrathecal clonidine in the treatment of intractable pain: A phase I/II study. Pain Medicine 2002, Vol:3(2):85-91.
38. Francisco GE. The role of intrathecal baclofen therapy in the upper motor neuron syndrome. Eura Medicophys 2004, 40(2):131-43.
39. Bowery NG, Hill DR, Hudson AL. Baclofen decreases neurotransmitter release in the mammalian CNS by action at a novel GABA receptor. Nature 1980, 283:92-4.
40. Mueller H, Zierski J, Dralle D, Börner U, Hoffmann O. The effect of intrathecal baclofen in electrical muscle activity in spasticity. J Neurol 1987, 234:234-52.
41. Zuniga RE, Perera S, Abram SE. Intrathecal baclofen: A useful agent in the treatment of well established complex regional pain syndrome. Reg Anesth Pain Med 2002, 27(1):99-3.
42. Slonimski M, Abram SE, Zuniga RE. Intrathecal baclofen in pain management. Reg Anesth Pain Med 2004, 29(3):269-76.
43. Shirley KW, Kothare S, Piatt JH, Adirim TA. Intrathecal baclofen overdose and withdrawal. Pedeatr Emerg Care 2006, 22:258-61.
44. Vender JR, Hester S, Waller JL, Rekito A, Lee MR. Identification and management of intrathecal baclofen pump complcations. A comparion of pediatric and adult patients. J Neurosurg 2006, 104(1):9-15. suppl